Karolinska Development: Where we stand after resolved on short-term finances
In November, after months of negotiations, 94. 2 percent of the convertible holders committed to converting or repurchase. Since then, the company has repaid the remaining part of the convertible loan and secured short-term finances via a loan of SEK 70 million from Sino Biopharma (largest shareholder in KD). This is where we stand regarding our coverage.